Historic FDA approval brings first gene therapy for genetic deafness
https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
Nature Biotechnology, published online: April 28, 2026; doi:10.1038/s41587-026-03145-w
This first-of-its-kind genetic medicine treats rare and profound otoferlin-related hearing loss and will be made available free of charge by Regeneron in the United States.
